Pasithea Therapeutics Cash Flow Statement (2021-2026) | KTTA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.73M-1.53M0.63M-0.33M-0.47M-0.40M-1.06M-0.27M-0.17M-0.02M-3.86M-3.87M-3.00M-3.18M-3.56M-3.72M-3.04M-10.11M-2.87M
Depreciation and Depletion (Quarter)
0.01M-0.00M-1.000.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M0.00M0.00M0.02M-421.00
Share-based Compensation (Quarter)
0.30M-0.27M0.72M0.14M0.10M0.11M0.16M0.18M0.20M0.10M0.07M0.07M0.00M0.00M0.12M0.06M0.09M0.14M
Cash from Discontinued Operations (Quarter)
-0.41M0.01M-0.63M-0.77M-0.18M-0.40M-0.01M-0.02M
Gains from Sales and Divestitures (Quarter)
0.10M0.01M
Gains from Investment Securities (Quarter)
0.25M-2.59M0.60M-0.42M0.40M-2.26M960.00-0.11M-0.04M-0.06M0.18M0.04M0.02M-0.00M-0.08M0.01M0.15M1.69M
Non-cash Items (Quarter)
0.10M0.10M0.10M0.25M0.01M0.85M0.06M0.10M0.10M0.48M0.11M0.11M0.14M0.09M0.12M0.72M
Cash from Operations (Quarter)
-0.50M-0.55M-1.74M-2.15M-1.94M-4.62M-3.19M-3.20M-3.08M-3.24M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M0.00M0.00M0.02M0.02M
Change in Working Capital
Change in Account Payables (Quarter)
-0.02M
Change in Accured Expenses (Quarter)
0.22M0.07M-0.08M0.03M0.03M0.41M0.28M-0.03M0.47M-0.05M0.68M-0.12M-1.04M-0.76M0.48M0.21M0.26M-0.24M-0.21M0.36M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.00M0.01M0.01M0.09M0.05M0.00M-0.02M-36.00
Sales of Property, Plant and Equipment (Quarter)
0.03M0.05M
Acquisitions (Quarter)
0.02M2.25M
Divestments (Quarter)
-0.11M-0.43M-0.16M0.07M0.00M0.32M
Cash from Investing Activities (Quarter)
-0.01M-0.00M0.07M-0.03M-2.34M-0.05M0.02M0.05M0.05M
Financing Activities
Other financing activities (Quarter)
0.30M0.01M-0.84M0.03M0.02M0.02M-0.07M0.02M0.02M0.02M-0.46M0.18M0.11M0.12M0.04M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
20.65M5.30M0.39M
Long-Term Debt Repayments (Quarter)
0.13M0.13M0.13M0.18M
Change in Capital Stock
Shares Issued (Quarter)
5.79M4.50M-0.48M871.001.28M0.73M53.41M
Misc.
Cash from Financing Activities (Quarter)
20.55M34.17M0.26M-0.13M-3.86M-0.02M1.47M5.74M-0.12M56.42M750.00
Exchange Rate Effect (Quarter)
-0.00M-0.01M-0.00M-0.04M-0.08M0.14M-0.00M-317.00-0.00M0.00M-620.00-0.00M-0.03M0.03M0.01M465.000.03M
Change in Cash (Quarter)
-0.50M20.00M32.40M-2.68M-2.33M-5.52M-9.29M-3.17M-3.27M-7.06M-3.25M-4.32M-4.04M1.39M-2.44M-1.58M1.88M-2.99M51.04M-4.76M
Free Cash Flow (Quarter)
-0.50M-0.55M-1.76M-2.15M-1.94M-4.63M-3.28M-3.26M-3.08M-3.22M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M
Net Cash Flow (Quarter)
-0.50M20.01M32.41M-2.15M-1.87M-4.65M-5.53M-2.99M-3.19M-7.05M-3.24M-4.32M-4.04M-3.12M-2.47M-1.58M1.87M-3.01M51.02M-4.79M